INFU
Price
$4.91
Change
-$0.07 (-1.41%)
Updated
Apr 17 closing price
Capitalization
186.74M
12 days until earnings call
SMLR
Price
$32.48
Change
+$1.49 (+4.81%)
Updated
Apr 17 closing price
Capitalization
203.76M
24 days until earnings call
Ad is loading...

INFU vs SMLR

Header iconINFU vs SMLR Comparison
Open Charts INFU vs SMLRBanner chart's image
InfuSystem Holdings
Price$4.91
Change-$0.07 (-1.41%)
Volume$133.64K
Capitalization186.74M
Semler Scientific
Price$32.48
Change+$1.49 (+4.81%)
Volume$311.35K
Capitalization203.76M
INFU vs SMLR Comparison Chart
Loading...
INFU
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SMLR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
INFU vs. SMLR commentary
Apr 19, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is INFU is a Hold and SMLR is a Hold.

Ad is loading...
COMPARISON
Comparison
Apr 19, 2025
Stock price -- (INFU: $4.91 vs. SMLR: $32.49)
Brand notoriety: INFU and SMLR are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: INFU: 95% vs. SMLR: 85%
Market capitalization -- INFU: $186.74M vs. SMLR: $203.76M
INFU [@Medical Specialties] is valued at $186.74M. SMLR’s [@Medical Specialties] market capitalization is $203.76M. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.31B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

INFU’s FA Score shows that 0 FA rating(s) are green whileSMLR’s FA Score has 0 green FA rating(s).

  • INFU’s FA Score: 0 green, 5 red.
  • SMLR’s FA Score: 0 green, 5 red.
According to our system of comparison, SMLR is a better buy in the long-term than INFU.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

INFU’s TA Score shows that 5 TA indicator(s) are bullish while SMLR’s TA Score has 4 bullish TA indicator(s).

  • INFU’s TA Score: 5 bullish, 4 bearish.
  • SMLR’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, INFU is a better buy in the short-term than SMLR.

Price Growth

INFU (@Medical Specialties) experienced а 0.00% price change this week, while SMLR (@Medical Specialties) price change was -0.44% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was +1.59%. For the same industry, the average monthly price growth was -9.77%, and the average quarterly price growth was -5.36%.

Reported Earning Dates

INFU is expected to report earnings on Aug 07, 2025.

SMLR is expected to report earnings on May 13, 2025.

Industries' Descriptions

@Medical Specialties (+1.59% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SMLR($204M) has a higher market cap than INFU($187M). INFU has higher P/E ratio than SMLR: INFU (195.13) vs SMLR (11.02). SMLR YTD gains are higher at: -39.843 vs. INFU (-41.893). SMLR has higher annual earnings (EBITDA): 23.6M vs. INFU (16.2M). SMLR has more cash in the bank: 57.2M vs. INFU (161K). SMLR has less debt than INFU: SMLR (160K) vs INFU (36.3M). INFU has higher revenues than SMLR: INFU (123M) vs SMLR (68.2M).
INFUSMLRINFU / SMLR
Capitalization187M204M92%
EBITDA16.2M23.6M69%
Gain YTD-41.893-39.843105%
P/E Ratio195.1311.021,771%
Revenue123M68.2M180%
Total Cash161K57.2M0%
Total Debt36.3M160K22,688%
FUNDAMENTALS RATINGS
INFU vs SMLR: Fundamental Ratings
INFU
SMLR
OUTLOOK RATING
1..100
918
VALUATION
overvalued / fair valued / undervalued
1..100
72
Overvalued
65
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
8437
PRICE GROWTH RATING
1..100
8662
P/E GROWTH RATING
1..100
9884
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

SMLR's Valuation (65) in the Medical Specialties industry is in the same range as INFU (72). This means that SMLR’s stock grew similarly to INFU’s over the last 12 months.

SMLR's Profit vs Risk Rating (100) in the Medical Specialties industry is in the same range as INFU (100). This means that SMLR’s stock grew similarly to INFU’s over the last 12 months.

SMLR's SMR Rating (37) in the Medical Specialties industry is somewhat better than the same rating for INFU (84). This means that SMLR’s stock grew somewhat faster than INFU’s over the last 12 months.

SMLR's Price Growth Rating (62) in the Medical Specialties industry is in the same range as INFU (86). This means that SMLR’s stock grew similarly to INFU’s over the last 12 months.

SMLR's P/E Growth Rating (84) in the Medical Specialties industry is in the same range as INFU (98). This means that SMLR’s stock grew similarly to INFU’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
INFUSMLR
RSI
ODDS (%)
Bullish Trend 2 days ago
59%
Bullish Trend 4 days ago
82%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
60%
Bullish Trend 2 days ago
75%
Momentum
ODDS (%)
Bearish Trend 2 days ago
76%
Bearish Trend 2 days ago
76%
MACD
ODDS (%)
Bullish Trend 2 days ago
63%
Bullish Trend 2 days ago
78%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
70%
Bearish Trend 2 days ago
73%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
80%
Bearish Trend 2 days ago
75%
Advances
ODDS (%)
Bullish Trend 4 days ago
71%
Bullish Trend 4 days ago
79%
Declines
ODDS (%)
Bearish Trend 2 days ago
78%
Bearish Trend 15 days ago
76%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
75%
Bearish Trend 2 days ago
77%
Aroon
ODDS (%)
Bearish Trend 2 days ago
73%
Bearish Trend 2 days ago
81%
View a ticker or compare two or three
Ad is loading...
INFU
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SMLR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
IDHIX17.480.17
+0.98%
Integrity Dividend Harvest I
TISLX10.590.10
+0.95%
Transamerica Intl Sust Eq R6
WBIRX27.230.23
+0.85%
William Blair International Growth R6
PMYYX38.630.07
+0.18%
Putnam Core Equity Fund Y
PRIGX16.760.01
+0.06%
T. Rowe Price Glbl Val Eq Cl I

INFU and

Correlation & Price change

A.I.dvisor indicates that over the last year, INFU has been loosely correlated with ALGN. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if INFU jumps, then ALGN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To INFU
1D Price
Change %
INFU100%
-1.41%
ALGN - INFU
37%
Loosely correlated
+2.53%
NVST - INFU
36%
Loosely correlated
+1.07%
XRAY - INFU
35%
Loosely correlated
+1.42%
SIBN - INFU
35%
Loosely correlated
+3.90%
SMLR - INFU
35%
Loosely correlated
+4.79%
More

SMLR and

Correlation & Price change

A.I.dvisor indicates that over the last year, SMLR has been loosely correlated with RDNT. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if SMLR jumps, then RDNT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SMLR
1D Price
Change %
SMLR100%
+4.79%
RDNT - SMLR
45%
Loosely correlated
-1.46%
RSLS - SMLR
44%
Loosely correlated
-14.71%
NNOX - SMLR
43%
Loosely correlated
+15.56%
TMCI - SMLR
39%
Loosely correlated
-1.07%
ALGN - SMLR
38%
Loosely correlated
+2.53%
More